Evidence map›Paper›PMID 32488246›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2020

Partial Activation of TrkB Receptors Corrects Interneuronal Calcium Channel Dysfunction and Reduces Epileptogenic Activity in Neocortex following Injury.

Feng Gu, Isabel Parada, Tao Yang, Frank M Longo, David A Prince

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Small-Molecule Trk Agonists: Where Do We Go from Here?Journal of medicinal chemistry · 2025
    Review
  2. Brain-derived neurotrophic factor scales presynaptic calcium transients to modulate excitatory neurotransmission.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Feng GuDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5122, USA.
Isabel ParadaDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5122, USA.
Tao YangDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5122, USA.
Frank M LongoDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5122, USA.
David A PrinceDepartment of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305-5122, USA.
Stanford University · US

Funding

Effects of TrkB Activation on Abnormalities in Neocortical FS InterneuronsR01NS082644 · NINDS · STANFORD UNIVERSITY · PI PRINCE, DAVID ALLAN · 2013 to 2022
$3.7M
NINDS NIH HHS R01 NS082644
6 · The paper itself

Abstract

Decreased GABAergic inhibition due to dysfunction of inhibitory interneurons plays an important role in post-traumatic epileptogenesis. Reduced N-current Ca2+ channel function in GABAergic terminals contributes to interneuronal abnormalities and neural circuit hyperexcitability in the partial neocortical isolation (undercut, UC) model of post-traumatic epileptogenesis. Because brain-derived neurotrophic factor (BDNF) supports the development and maintenance of interneurons, we hypothesized that the activation of BDNF tropomyosin kinase B (TrkB) receptors by a small molecule, TrkB partial agonist, PTX BD4-3 (BD), would correct N channel abnormalities and enhance inhibitory synaptic transmission in UC cortex. Immunocytochemistry (ICC) and western blots were used to quantify N- and P/Q-type channels. We recorded evoked (e)IPSCs and responses to N and P/Q channel blockers to determine the effects of BD on channel function. Field potential recordings were used to determine the effects of BD on circuit hyperexcitability. Chronic BD treatment 1) upregulated N and P/Q channel immunoreactivity in GABAergic terminals; 2) increased the effects of N or P/Q channel blockade on evoked inhibitory postsynaptic currents (eIPSCs); 3) increased GABA release probability and the frequency of sIPSCs; and 4) reduced the incidence of epileptiform discharges in UC cortex. The results suggest that chronic TrkB activation is a promising approach for rescuing injury-induced calcium channel abnormalities in inhibitory terminals, thereby improving interneuronal function and suppressing circuit hyperexcitability.

Indexed as

AnimalsBrain InjuriesCalcium ChannelsEpilepsyInterneuronsMaleNeocortexRatsRats, Sprague-DawleyReceptor, trkBSynaptic TransmissionCalcium ChannelsNtrk2 protein, ratReceptor, trkBcalcium channelcortical injuryepileptogenesisinterneuronTrkB

Identifiers

PMID32488246
PMCPMC7391412
OpenAlexW3031007212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.